90 related articles for article (PubMed ID: 26621338)
1. Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.
Leich E; Hoster E; Wartenberg M; Unterhalt M; Siebert R; Koch K; Klapper W; Engelhard M; Puppe B; Horn H; Staiger AM; Stuhlmann-Laeisz C; Bernd HW; Feller AC; Hummel M; Lenze D; Stein H; Hartmann S; Hansmann ML; Möller P; Hiddemann W; Dreyling M; Ott G; Rosenwald A;
Leukemia; 2016 Apr; 30(4):854-60. PubMed ID: 26621338
[TBL] [Abstract][Full Text] [Related]
2. ''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases.
Weinberg OK; Ai WZ; Mariappan MR; Shum C; Levy R; Arber DA
J Mol Diagn; 2007 Sep; 9(4):530-7. PubMed ID: 17652637
[TBL] [Abstract][Full Text] [Related]
3. Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
Correia C; Maurer MJ; McDonough SJ; Schneider PA; Ross PE; Novak AJ; Feldman AL; Cerhan JR; Slager SL; Witzig TE; Eckloff BW; Li H; Nowakowski GS; Kaufmann SH
Blood Cancer J; 2023 May; 13(1):81. PubMed ID: 37193683
[TBL] [Abstract][Full Text] [Related]
4. [CD23 positive, BCL2 rearrangement-negative germinal centre lymphomas].
Menter T; Quintanilla-Martinez L
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):160-163. PubMed ID: 37932478
[TBL] [Abstract][Full Text] [Related]
5. Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
Okosun J; Wolfson RL; Wang J; Araf S; Wilkins L; Castellano BM; Escudero-Ibarz L; Al Seraihi AF; Richter J; Bernhart SH; Efeyan A; Iqbal S; Matthews J; Clear A; Guerra-Assunção JA; Bödör C; Quentmeier H; Mansbridge C; Johnson P; Davies A; Strefford JC; Packham G; Barrans S; Jack A; Du MQ; Calaminici M; Lister TA; Auer R; Montoto S; Gribben JG; Siebert R; Chelala C; Zoncu R; Sabatini DM; Fitzgibbon J
Nat Genet; 2016 Feb; 48(2):183-8. PubMed ID: 26691987
[TBL] [Abstract][Full Text] [Related]
6. Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.
Morin RD; Assouline S; Alcaide M; Mohajeri A; Johnston RL; Chong L; Grewal J; Yu S; Fornika D; Bushell K; Nielsen TH; Petrogiannis-Haliotis T; Crump M; Tosikyan A; Grande BM; MacDonald D; Rousseau C; Bayat M; Sesques P; Froment R; Albuquerque M; Monczak Y; Oros KK; Greenwood C; Riazalhosseini Y; Arseneault M; Camlioglu E; Constantin A; Pan-Hammarstrom Q; Peng R; Mann KK; Johnson NA
Clin Cancer Res; 2016 May; 22(9):2290-300. PubMed ID: 26647218
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
Ljungström V; Cortese D; Young E; Pandzic T; Mansouri L; Plevova K; Ntoufa S; Baliakas P; Clifford R; Sutton LA; Blakemore SJ; Stavroyianni N; Agathangelidis A; Rossi D; Höglund M; Kotaskova J; Juliusson G; Belessi C; Chiorazzi N; Panagiotidis P; Langerak AW; Smedby KE; Oscier D; Gaidano G; Schuh A; Davi F; Pott C; Strefford JC; Trentin L; Pospisilova S; Ghia P; Stamatopoulos K; Sjöblom T; Rosenquist R
Blood; 2016 Feb; 127(8):1007-16. PubMed ID: 26675346
[TBL] [Abstract][Full Text] [Related]
8. Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
[TBL] [Abstract][Full Text] [Related]
9. Treatment of patients with transformed lymphoma.
Montoto S
Hematology Am Soc Hematol Educ Program; 2015; 2015():625-30. PubMed ID: 26637780
[TBL] [Abstract][Full Text] [Related]
10. Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy.
Kelly PN; Romero DL; Yang Y; Shaffer AL; Chaudhary D; Robinson S; Miao W; Rui L; Westlin WF; Kapeller R; Staudt LM
J Exp Med; 2015 Dec; 212(13):2189-201. PubMed ID: 26621451
[TBL] [Abstract][Full Text] [Related]
11. IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma.
Pandey S; Mourcin F; Marchand T; Nayar S; Guirriec M; Pangault C; Monvoisin C; Amé-Thomas P; Guilloton F; Dulong J; Coles M; Fest T; Mottok A; Barone F; Tarte K
Blood; 2017 May; 129(18):2507-2518. PubMed ID: 28202459
[TBL] [Abstract][Full Text] [Related]
12. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.
Dupont T; Yang SN; Patel J; Hatzi K; Malik A; Tam W; Martin P; Leonard J; Melnick A; Cerchietti L
Oncotarget; 2016 Jan; 7(3):3520-32. PubMed ID: 26657288
[TBL] [Abstract][Full Text] [Related]
13. Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing.
Zamò A; Pischimarov J; Schlesner M; Rosenstiel P; Bomben R; Horn H; Grieb T; Nedeva T; López C; Haake A; Richter J; Trümper L; Lawerenz C; Klapper W; Möller P; Hummel M; Lenze D; Szczepanowski M; Flossbach L; Schreder M; Gattei V; Ott G; Siebert R; Rosenwald A; Leich E
Leukemia; 2018 Mar; 32(3):685-693. PubMed ID: 28824170
[TBL] [Abstract][Full Text] [Related]
14. Follicular Lymphoma Microenvironment: An Intricate Network Ready for Therapeutic Intervention.
Dobaño-López C; Araujo-Ayala F; Serrat N; Valero JG; Pérez-Galán P
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562694
[TBL] [Abstract][Full Text] [Related]
15. Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease.
Nann D; Ramis-Zaldivar JE; Müller I; Gonzalez-Farre B; Schmidt J; Egan C; Salmeron-Villalobos J; Clot G; Mattern S; Otto F; Mankel B; Colomer D; Balagué O; Szablewski V; Lome-Maldonado C; Leoncini L; Dojcinov S; Chott A; Copie-Bergman C; Bonzheim I; Fend F; Jaffe ES; Campo E; Salaverria I; Quintanilla-Martinez L
Blood Adv; 2020 Nov; 4(22):5652-5665. PubMed ID: 33211828
[TBL] [Abstract][Full Text] [Related]
16. Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.
Kalmbach S; Grau M; Zapukhlyak M; Leich E; Jurinovic V; Hoster E; Staiger AM; Kurz KS; Weigert O; Gaitzsch E; Passerini V; Engelhard M; Herfarth K; Beiske K; Micci F; Möller P; Bernd HW; Feller AC; Klapper W; Stein H; Hansmann ML; Hartmann S; Dreyling M; Holte H; Lenz G; Rosenwald A; Ott G; Horn H;
Leukemia; 2023 Oct; 37(10):2058-2065. PubMed ID: 37563306
[TBL] [Abstract][Full Text] [Related]
17. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
Salaverria I; Weigert O; Quintanilla-Martinez L
Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
[TBL] [Abstract][Full Text] [Related]
18. Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Biological Data.
Kurz KS; Kalmbach S; Ott M; Staiger AM; Ott G; Horn H
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765742
[TBL] [Abstract][Full Text] [Related]
19. Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas.
Horn H; Jurinovic V; Leich E; Kalmbach S; Bausinger J; Staiger AM; Kurz KS; Möller P; Bernd HW; Feller AC; Koch K; Klapper W; Stein H; Hansmann ML; Hartmann S; Scheubeck G; Dreyling M; Hiddemann W; Herfarth K; Engelhard M; Rosenwald A; Hoster E; Ott G
Hemasphere; 2022 Sep; 6(9):e767. PubMed ID: 35974958
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
